A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction

From MaRDI portal
Publication:2187588

DOI10.1016/j.jtbi.2003.11.024zbMath1439.92068OpenAlexW2124356165WikidataQ52000851 ScholiaQ52000851MaRDI QIDQ2187588

Natasha K. Li, Helen Moore

Publication date: 3 June 2020

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jtbi.2003.11.024



Related Items

A quantitative study on the role of TKI combined with Wnt/\(\beta\)-catenin signaling and IFN-\(\alpha\) in the treatment of CML through deterministic and stochastic approaches, A quantitative cellular automaton model of in vitro multicellular spheroid tumour growth, Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer, Ordinary differential equation models for adoptive immunotherapy, Optimal chemotherapy schedules from tumor entropy, Mathematical modeling approach of cancer immunoediting reveals new insights in targeted-therapy and timing plan of cancer treatment, Modelling and investigation of the \(\mathrm{CD}4^+\) T cells -- macrophages paradox in melanoma immunotherapies, T cell state transition produces an emergent change detector, Stability and controllability issues in mathematical modeling of the intensive treatment of leukemia, Optimization of combined leukemia therapy by finite-dimensional optimal control modeling, A nonlinear mathematical model of cell-mediated immune response for tumor phenotypic heterogeneity, A mathematical model with time-varying delays in the combined treatment of chronic myeloid leukemia, On the global dynamics of a chronic myelogenous leukemia model, Methods for determining key components in a mathematical model for tumor-immune dynamics in multiple myeloma, Predator-prey equations with constant harvesting and planting, Bridging blood cancers and inflammation: the reduced cancitis model, Tractable Model of Malignant Gliomas Immunotherapy with Discrete Time Delays, A dynamical model of tumour immunotherapy, Optimal control analysis of a leukemia model under imatinib treatment, Optimal control of treatment in a mathematical model of chronic myelogenous leukemia, Hopf bifurcation in a solid avascular tumour growth model with two discrete delays, To cure or not to cure: consequences of immunological interactions in CML treatment, Dependence of CD8 T cell response upon antigen load during primary infection., Optimization of combination therapy for chronic myeloid leukemia with dosing constraints, Non-autonomous second order differential inclusions with a stabilizing effect, Feedback mechanisms control coexistence in a stem cell model of acute myeloid leukaemia, Mathematical modeling of tumor growth: the MCF-7 breast cancer cell line, Mathematics + Cancer: An Undergraduate "Bridge" Course in Applied Mathematics, Mathematical analysis and optimal control applied to the treatment of leukemia, Post-transplantation dynamics of the immune response to chronic myelogenous leukemia, Modelling and analysis of delayed tumour-immune system with hunting T-cells, Mathematical models of leukaemia and its treatment: a review, Modeling the effect of activation of CD\(4^+\) T cells on HIV dynamics



Cites Work